Nature's Sunshine Products, Inc. (NATR)
- Previous Close
18.70 - Open
18.88 - Bid 19.08 x 100
- Ask 19.33 x 100
- Day's Range
18.73 - 19.48 - 52 Week Range
10.06 - 21.72 - Volume
47,213 - Avg. Volume
53,409 - Market Cap (intraday)
362.372M - Beta (5Y Monthly) 0.82
- PE Ratio (TTM)
25.05 - EPS (TTM)
0.77 - Earnings Date May 7, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Mar 26, 2021
- 1y Target Est
24.00
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
www.naturessunshine.com814
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NATR
Performance Overview: NATR
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NATR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NATR
Valuation Measures
Market Cap
351.29M
Enterprise Value
283.84M
Trailing P/E
24.29
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.82
Price/Book (mrq)
2.28
Enterprise Value/Revenue
0.64
Enterprise Value/EBITDA
8.85
Financial Highlights
Profitability and Income Statement
Profit Margin
3.38%
Return on Assets (ttm)
6.37%
Return on Equity (ttm)
10.71%
Revenue (ttm)
445.32M
Net Income Avi to Common (ttm)
15.08M
Diluted EPS (ttm)
0.77
Balance Sheet and Cash Flow
Total Cash (mrq)
82.37M
Total Debt/Equity (mrq)
9.35%
Levered Free Cash Flow (ttm)
39.56M
Research Analysis: NATR
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell